Guidance for conducting systematic scoping reviews
Reviews of primary research are becoming more common as evidence-based practice gains recognition as the benchmark for care, and the number of, and access to, primary research s...
Publications
Explore 838 academic publications
Showing 12 of
838 publications
Planetary Boundaries: Exploring the Safe Operating Space for Humanity
"Anthropogenic pressures on the Earth System have reached a scale where abrupt global environmental change can no longer be excluded. We propose a new approach to global sustain...
Science, Technology and Innovation (STI) Policy for Sustainable Development
Recent developments about the extension of high-order Residual-Based Compact schemes to unsteady flows and complex configurations are discussed, with application to scale-resolv...
BEAST 2: A Software Platform for Bayesian Evolutionary Analysis
We present a new open source, extensible and flexible software platform for Bayesian evolutionary analysis called BEAST 2. This software platform is a re-design of the popular B...
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
U.S. Centers for Disease Control and Prevention, National Institute of Allergy and Infectious Diseases, National Institute of General Medical Sciences, and Alexander von Humbold...
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
The gene-expression profile we studied is a more powerful predictor of the outcome of disease in young patients with breast cancer than standard systems based on clinical and hi...
The Astropy Project: Building an Open-science Project and Status of the v2.0 Core Package<sup>*</sup>
Abstract The Astropy Project supports and fosters the development of open-source and openly developed Python packages that provide commonly needed functionality to the astronomi...
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
In patients with previously untreated metastatic nonsquamous NSCLC without EGFR or ALK mutations, the addition of pembrolizumab to standard chemotherapy of pemetrexed and a plat...